Cargando…

Review of Fibromyalgia (FM) Syndrome Treatments

Background: Fibromyalgia (FM) is a disease characterized by widespread musculoskeletal chronic pain that impairs the patient’s quality of life and is considered a somatization disorder. The symptoms of the disease also affect the patient mentally, mainly since invisible pain is the only thing that i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Biton, Liraz, Buskila, Dan, Nissanholtz-Gannot, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566124/
https://www.ncbi.nlm.nih.gov/pubmed/36231406
http://dx.doi.org/10.3390/ijerph191912106
_version_ 1784809064577892352
author Cohen-Biton, Liraz
Buskila, Dan
Nissanholtz-Gannot, Rachel
author_facet Cohen-Biton, Liraz
Buskila, Dan
Nissanholtz-Gannot, Rachel
author_sort Cohen-Biton, Liraz
collection PubMed
description Background: Fibromyalgia (FM) is a disease characterized by widespread musculoskeletal chronic pain that impairs the patient’s quality of life and is considered a somatization disorder. The symptoms of the disease also affect the patient mentally, mainly since invisible pain is the only thing that indicates its existence. A typical symptom that characterizes FM patients is the lack of acceptance of the disease since its pathophysiology is not elucidated, hence the deficiencies in its management, or rather, cognitively, the belief that there is no disease to manage. The current paper aims to shed light on the new treatment methods at a holistic level, that is, cognitive, physical, and pharmacological therapies. Method: A literature review was carried out that discusses treatment methods that help alleviate the pain, accept it, and manage the symptoms of the disease. Results: FM symptoms can be treated by taking a broad view of treatment that will include a response to the mind through pain management, response to the body through physical activity, and response to the pain through pharmacological treatment. Conclusions: Today, there is an evolutionary view that accepts FM and chronic pain diseases as syndromes in which the pain is the disease; therefore, the response to this disease can be applied through three channels: physical, bodily, and mental.
format Online
Article
Text
id pubmed-9566124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95661242022-10-15 Review of Fibromyalgia (FM) Syndrome Treatments Cohen-Biton, Liraz Buskila, Dan Nissanholtz-Gannot, Rachel Int J Environ Res Public Health Article Background: Fibromyalgia (FM) is a disease characterized by widespread musculoskeletal chronic pain that impairs the patient’s quality of life and is considered a somatization disorder. The symptoms of the disease also affect the patient mentally, mainly since invisible pain is the only thing that indicates its existence. A typical symptom that characterizes FM patients is the lack of acceptance of the disease since its pathophysiology is not elucidated, hence the deficiencies in its management, or rather, cognitively, the belief that there is no disease to manage. The current paper aims to shed light on the new treatment methods at a holistic level, that is, cognitive, physical, and pharmacological therapies. Method: A literature review was carried out that discusses treatment methods that help alleviate the pain, accept it, and manage the symptoms of the disease. Results: FM symptoms can be treated by taking a broad view of treatment that will include a response to the mind through pain management, response to the body through physical activity, and response to the pain through pharmacological treatment. Conclusions: Today, there is an evolutionary view that accepts FM and chronic pain diseases as syndromes in which the pain is the disease; therefore, the response to this disease can be applied through three channels: physical, bodily, and mental. MDPI 2022-09-24 /pmc/articles/PMC9566124/ /pubmed/36231406 http://dx.doi.org/10.3390/ijerph191912106 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cohen-Biton, Liraz
Buskila, Dan
Nissanholtz-Gannot, Rachel
Review of Fibromyalgia (FM) Syndrome Treatments
title Review of Fibromyalgia (FM) Syndrome Treatments
title_full Review of Fibromyalgia (FM) Syndrome Treatments
title_fullStr Review of Fibromyalgia (FM) Syndrome Treatments
title_full_unstemmed Review of Fibromyalgia (FM) Syndrome Treatments
title_short Review of Fibromyalgia (FM) Syndrome Treatments
title_sort review of fibromyalgia (fm) syndrome treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566124/
https://www.ncbi.nlm.nih.gov/pubmed/36231406
http://dx.doi.org/10.3390/ijerph191912106
work_keys_str_mv AT cohenbitonliraz reviewoffibromyalgiafmsyndrometreatments
AT buskiladan reviewoffibromyalgiafmsyndrometreatments
AT nissanholtzgannotrachel reviewoffibromyalgiafmsyndrometreatments